More than 60 million Americans battle insomnia, and counting sheep, reading dull books or skipping naps isn't helping. Here ...

FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in ...

FOX 13's Linda Hurtado explains how the new technology works. Biden signs defense bill despite objections to ban on ...

Here's a look at the latest headlines impacting your health from News 8.

The Apple Watch is one of the most accurate and consistent sleep trackers we’ve tested, but the insights available differ slightly from rival brands. Apple only added stage analysis in 2022, but ...

Stocks closed higher on Wall Street at the start of a holiday-shortened week. The S&P 500 rose 0.7% Monday. Several big ...

Researchers from Washington University in St. Louis found people who took suvorexant, a common treatment for insomnia, for ...

The obesity medication Zepbound can be used on-label to treat obstructive sleep apnea in adults with obesity, the FDA ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

Obstructive sleep apnea is more common in men than women. Up to 34% of U.S. men have OSA compared to 17% of U.S. women, according to the American Academy of Family Physicians. Common signs of ...

Nearly 936 million adults worldwide are fighting an invisible battle each night as they sleep. The culprit: sleep apnea, a condition ... recognizing common warning signs such as loud snoring ...